Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Get Free Report) saw strong trading volume on Tuesday . Finally, Leerink Partners set a $52.00 price target on Edgewise Therapeutics in a research report on Tuesday, June 16th. Get Edgewise Therapeutics alerts:View Our Latest Report on Edgewise TherapeuticsEdgewise Therapeutics Price PerformanceThe company’s 50-day moving average is $38.59 and its two-hundred day moving average is $33.65. Edgewise Therapeutics (NASDAQ:EWTX – Get Free Report) last released its earnings results on Thursday, May 7th. Read MoreReceive News & Ratings for Edgewise Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edgewise Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.